IL81317A - 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL81317A
IL81317A IL81317A IL8131787A IL81317A IL 81317 A IL81317 A IL 81317A IL 81317 A IL81317 A IL 81317A IL 8131787 A IL8131787 A IL 8131787A IL 81317 A IL81317 A IL 81317A
Authority
IL
Israel
Prior art keywords
benzazecine
chloro
hexahydro
preparation
pharmaceutical compositions
Prior art date
Application number
IL81317A
Other languages
English (en)
Other versions
IL81317A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL81317A0 publication Critical patent/IL81317A0/xx
Publication of IL81317A publication Critical patent/IL81317A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
    • C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D227/08—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL81317A 1986-01-23 1987-01-20 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them IL81317A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH26686 1986-01-23

Publications (2)

Publication Number Publication Date
IL81317A0 IL81317A0 (en) 1987-08-31
IL81317A true IL81317A (en) 1991-06-30

Family

ID=4183090

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81317A IL81317A (en) 1986-01-23 1987-01-20 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (4) US4732979A (cs)
EP (1) EP0230967B1 (cs)
JP (1) JPS62169770A (cs)
KR (1) KR910000659B1 (cs)
CN (1) CN1013111B (cs)
AT (1) ATE68790T1 (cs)
AU (1) AU590042B2 (cs)
CS (1) CS258147B2 (cs)
DD (1) DD264431A5 (cs)
DE (1) DE3773950D1 (cs)
DK (1) DK35887A (cs)
FI (1) FI82931C (cs)
GB (1) GB2185744B (cs)
HU (1) HU197883B (cs)
IE (1) IE870167L (cs)
IL (1) IL81317A (cs)
IS (1) IS3190A7 (cs)
MC (1) MC1795A1 (cs)
MT (1) MTP996B (cs)
MW (1) MW187A1 (cs)
NO (1) NO167385C (cs)
NZ (1) NZ218987A (cs)
OA (1) OA08469A (cs)
PH (1) PH22879A (cs)
PL (1) PL263796A1 (cs)
PT (1) PT84181B (cs)
TN (1) TNSN87006A1 (cs)
YU (1) YU7087A (cs)
ZA (1) ZA87407B (cs)
ZW (1) ZW1087A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81317A (en) * 1986-01-23 1991-06-30 Hoffmann La Roche 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them
IN167395B (cs) * 1987-07-21 1990-10-20 Hoffmann La Roche
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
ES2169026T3 (es) * 1991-08-21 2002-07-01 Lilly Co Eli Benzo(f)quinolinonas como inhibidores de 5-alfa-reductasa.
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
ES2125884T3 (es) * 1991-08-21 1999-03-16 Lilly Co Eli Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
WO1994022444A1 (en) * 1993-03-29 1994-10-13 Smithkline Beecham Corporation Tricyclic compounds for inhibiting platelet aggregation
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
DE69515321T2 (de) * 1994-09-20 2000-08-24 The Regents Of The University Of California, Oakland Brefeldin a und analoge zur verbesserung synaptischer übertragungen
US20050067341A1 (en) * 2003-09-25 2005-03-31 Green Dennis H. Continuous production membrane water treatment plant and method for operating same
US7094331B2 (en) * 2003-11-05 2006-08-22 Marathon Ashland Petroleum Llc Viscosity modification of heavy hydrocarbons using dihydric alcohols
US20090263439A1 (en) * 2008-04-18 2009-10-22 The Procter & Gamble Company Antimicrobial Preservative Free Wipe
CN106117028B (zh) * 2016-06-14 2019-01-01 浙江永太药业有限公司 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE442586A (cs) * 1940-07-31
JPS5129710B2 (cs) * 1972-09-09 1976-08-27
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
US4521423A (en) * 1983-10-31 1985-06-04 Ayerst, Mckenna & Harrison, Ltd. 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them
IL81317A (en) * 1986-01-23 1991-06-30 Hoffmann La Roche 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT84181A (pt) 1987-02-01
ATE68790T1 (de) 1991-11-15
NO870280D0 (no) 1987-01-22
CS41887A2 (en) 1987-11-12
IS3190A7 (is) 1987-07-24
FI82931C (fi) 1991-05-10
DK35887D0 (da) 1987-01-22
DK35887A (da) 1987-07-24
NO167385C (no) 1991-10-30
US4732979A (en) 1988-03-22
PT84181B (pt) 1989-09-14
JPS62169770A (ja) 1987-07-25
CN87100312A (zh) 1987-09-09
MC1795A1 (fr) 1987-10-22
GB8701416D0 (en) 1987-02-25
EP0230967A2 (de) 1987-08-05
GB2185744A (en) 1987-07-29
NO870280L (no) 1987-07-24
IE870167L (en) 1987-07-23
PH22879A (en) 1989-01-19
US4749791A (en) 1988-06-07
NO167385B (no) 1991-07-22
KR910000659B1 (ko) 1991-01-31
MTP996B (en) 1987-08-21
PL263796A1 (en) 1988-10-27
YU7087A (en) 1988-06-30
EP0230967B1 (de) 1991-10-23
US4957911A (en) 1990-09-18
OA08469A (fr) 1988-07-29
MW187A1 (en) 1987-10-14
AU6791187A (en) 1987-07-30
KR870007132A (ko) 1987-08-17
ZA87407B (en) 1987-09-30
CN1013111B (zh) 1991-07-10
DE3773950D1 (de) 1991-11-28
EP0230967A3 (en) 1988-08-31
CS258147B2 (en) 1988-07-15
TNSN87006A1 (fr) 1990-01-01
HUT44519A (en) 1988-03-28
IL81317A0 (en) 1987-08-31
FI870220A0 (fi) 1987-01-20
GB2185744B (en) 1989-12-06
US4876340A (en) 1989-10-24
HU197883B (en) 1989-06-28
ZW1087A1 (en) 1987-08-12
DD264431A5 (de) 1989-02-01
FI870220A7 (fi) 1987-07-24
FI82931B (fi) 1991-01-31
AU590042B2 (en) 1989-10-26
NZ218987A (en) 1990-04-26

Similar Documents

Publication Publication Date Title
AU590042B2 (en) Benzazecine Derivatives
GB2126226B (en) Pyridine derivatives
NZ216172A (en) Nucleosides and pharmaceutical compositions
MY103801A (en) Dideoxydidehydrocarbocyclic nucleosides
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
NO179834C (no) Substituerte cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler
IL84359A0 (en) Substituted cephalosporin sulfones,their preparation and pharmaceutical compositions containing them
IL85945A0 (en) Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation
DK192988A (da) Dihydropyridinamider, deres fremstilling og anvendelse
IL87799A0 (en) Saccharide derivatives,their preparation and pharmaceutical compositions containing them
SE8304062L (sv) Nya diklorerade derivat av 16alfa-metyl-pregnanserien, framstellning derav, anvendning derav som lekemedel och kompositioner innehallande dem
NO911798D0 (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
NZ224812A (en) Derivatives of 2',3'-dideoxycytidine and pharmaceutical compositions
IL87104A0 (en) Pest-combating compositions comprising derivatives of 2,3-diaminomaleonitrile,certain such new derivatives and their preparation
OA09021A (fr) Nouveaux dérivés de l'octahydro indeno-furane, leur préparation et compositions thérapeutiques en contenant.
IL85508A (en) 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them